Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
192.00K | 0.00 | 0.00 | 0.00 | 0.00 | 120.00K | Gross Profit |
95.00K | 0.00 | -374.00K | -373.00K | -195.00K | -63.00K | EBIT |
-77.48M | -70.58M | -43.00M | 8.49M | -36.87M | -18.46M | EBITDA |
-77.41M | -35.39M | 0.00 | -87.59M | -36.66M | -23.03M | Net Income Common Stockholders |
-19.05M | -35.32M | -40.33M | -87.50M | -34.51M | -22.81M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
124.88M | 140.18M | 51.10M | 56.41M | 84.83M | 114.19M | Total Assets |
161.31M | 177.41M | 89.07M | 92.79M | 170.55M | 197.19M | Total Debt |
880.00K | 954.00K | 383.00K | 746.00K | 769.00K | 144.00K | Net Debt |
-7.62M | -19.59M | -4.23M | -55.66M | -84.06M | -114.05M | Total Liabilities |
46.73M | 59.27M | 81.86M | 8.61M | 6.55M | 6.59M | Stockholders Equity |
114.58M | 118.14M | 7.21M | 84.18M | 164.00M | 190.60M |
Cash Flow | Free Cash Flow | ||||
-54.59M | -47.27M | -39.53M | -28.42M | -28.91M | -15.21M | Operating Cash Flow |
-54.59M | -47.27M | -39.53M | -28.42M | -28.91M | -15.21M | Investing Cash Flow |
-76.20M | -70.31M | -45.29M | 0.00 | 0.00 | 11.04M | Financing Cash Flow |
133.64M | 133.52M | 33.02M | 0.00 | -449.00K | 109.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
57 Neutral | $127.37M | 38.10 | 10.42% | ― | 0.18% | -55.15% | |
54 Neutral | $5.28B | 3.29 | -45.38% | 2.80% | 16.77% | -0.08% | |
52 Neutral | $168.74M | ― | -139.01% | ― | -90.97% | -27.47% | |
51 Neutral | $243.03M | ― | 322.49% | ― | -30.66% | 36.48% | |
47 Neutral | $426.17M | ― | -60.67% | ― | ― | 3.88% | |
45 Neutral | $163.26M | ― | -43.31% | ― | 95.23% | 15.55% | |
35 Underperform | $181.44M | ― | -83.30% | ― | ― | 69.29% |
Eledon Pharmaceuticals announced an amendment to the employment agreement of its CEO, David-Alexandre Gros, adjusting the market value cap for his performance bonus. The CEO’s bonus structure has been altered, allowing for a maximum bonus of $15 million if the company’s market value reaches $1.5 billion, with linear interpolation determining payouts between set thresholds.